NYSE:ABTMedical Equipment
Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth Focus
Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earnings per share, refocusing attention on future growth drivers.
See our latest analysis for Abbott Laboratories.
The latest earnings release appears to have reset expectations for Abbott Laboratories, with the share price up 13.9% over 30 days and 13.1% over 90 days, even as the year to date share price return and one year total...